Article
wer
Welcome
Ophthalmology Times welcomes ophthalmic professionals from around the world to Orlando. Our four-day coverage of this year’s meeting of the American Academy of Ophthalmology begins today and includes breaking news, the latest research findings, and reports of interest to readers.
Enjoy the meeting!
CATARACT
AAO 'strongly opposes' MedPAC proposal
San Francisco and Washington, DC-The American Academy of Ophthalmology (AAO) “strongly opposes” a recent proposal by the Medicare Payment Advisory Commission (MedPAC) to fix the formula used to establish Medicare payments to physicians, the organization said in a prepared statement.» MORE
Vision Expo West uses social media
Las Vegas-Attendees at last week’s International Vision Expo West kept up with the latest news at the meeting via Facebook, Twitter, LinkedIn, and YouTube. » MORE
RETINA
Glistening-free, hydrophobic acrylic IOL debuts
Vienna, Austria-A new glistening-free, hydrophobic acrylic IOL (enVista, Bausch + Lomb) debuted at the annual meeting of the European Society of Cataract and Refractive Surgeons here. » MORE
REFRACTIVE
Companies join forces to market laser in Europe
Rotterdam, Netherlands, and Orlando-Topcon Europe Medical BV will distribute and market the LensAR Inc. product line (including a laser) in Europe under the terms of an agreement between the two companies. They expect commercial sales to start on the continent in the first quarter of next year.» MORE
GLAUCOMA
David F. Weeks to step down at RPB
New York-David F. Weeks will step down from his role as chairman and chief executive officer of Research to Prevent Blindness (RPB) at the end of this year after having served the organization for 50 years. » MORE
Exhibit Hall Hours
Saturday, October 22
9 a.m. â 5 p.m.
Sunday, October 23
9 a.m. â 5 p.m.
Monday, October 24
9 a.m. â 5 p.m.
Tuesday, October 25
9 a.m. â 3 p.m.
We welcome your feedback!
Please send your comments to:
Mark Dlugoss
Editor-in-Chief
Advanstar Eye Health Group
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.